175 related articles for article (PubMed ID: 38617459)
21. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
Dent J
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
[TBL] [Abstract][Full Text] [Related]
22. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
23. A new artificial intelligence system successfully detects and localises early neoplasia in Barrett's esophagus by using convolutional neural networks.
Hussein M; González-Bueno Puyal J; Lines D; Sehgal V; Toth D; Ahmad OF; Kader R; Everson M; Lipman G; Fernandez-Sordo JO; Ragunath K; Esteban JM; Bisschops R; Banks M; Haefner M; Mountney P; Stoyanov D; Lovat LB; Haidry R
United European Gastroenterol J; 2022 Jul; 10(6):528-537. PubMed ID: 35521666
[TBL] [Abstract][Full Text] [Related]
24. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
25. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
[TBL] [Abstract][Full Text] [Related]
26. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
27. Cancer Risk in Barrett's Esophagus: A Clinical Review.
Beydoun AS; Stabenau KA; Altman KW; Johnston N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
[TBL] [Abstract][Full Text] [Related]
28. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later?
Jones B; Wani S
Curr Gastroenterol Rep; 2020 Dec; 22(12):61. PubMed ID: 33277663
[TBL] [Abstract][Full Text] [Related]
30. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus.
Tsai TT; Bongiorno PF; Orringer MB; Beer DG
Cancer Detect Prev; 1997; 21(4):326-31. PubMed ID: 9232323
[TBL] [Abstract][Full Text] [Related]
31. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
32. Barrett's Esophagus: Diagnosis, Management, and Key Updates.
Chang K; Jackson CS; Vega KJ
Gastroenterol Clin North Am; 2021 Dec; 50(4):751-768. PubMed ID: 34717869
[TBL] [Abstract][Full Text] [Related]
33. Role of brush cytology in the diagnosis of Barrett's esophagus: an analysis of eight cases.
Padmavathy F; Siddaraju N; Sistla SC
Diagn Cytopathol; 2011 Jan; 39(1):60-4. PubMed ID: 21162095
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study.
Isenberg G; Sivak MV; Chak A; Wong RC; Willis JE; Wolf B; Rowland DY; Das A; Rollins A
Gastrointest Endosc; 2005 Dec; 62(6):825-31. PubMed ID: 16301020
[TBL] [Abstract][Full Text] [Related]
35. Barrett's esophagus and Barrett's carcinoma.
von Rahden BH; Stein HJ; Siewert JR
Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
[TBL] [Abstract][Full Text] [Related]
36. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.
Spechler SJ
Med Clin North Am; 2002 Nov; 86(6):1423-45, vii. PubMed ID: 12510459
[TBL] [Abstract][Full Text] [Related]
37. Artificial intelligence technique in detection of early esophageal cancer.
Huang LM; Yang WJ; Huang ZY; Tang CW; Li J
World J Gastroenterol; 2020 Oct; 26(39):5959-5969. PubMed ID: 33132647
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of a simplified narrow-band imaging classification system for Barrett's esophagus for novice endoscopists.
Furuhashi H; Goda K; Shimizu Y; Kato M; Takahashi M; Dobashi A; Hirata K; Oba A; Shigesawa T; Inoue M; Matsui H; Kinoshita C; Ando Y; Ikegami M; Shimoda T; Kato M
J Gastroenterol; 2019 Jul; 54(7):587-596. PubMed ID: 30603885
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Streitz JM; Ellis FH; Tilden RL; Erickson RV
Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
[TBL] [Abstract][Full Text] [Related]
40. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
Peitz U; Malfertheiner P
Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
